Indication & Dosage :
GLYXAMBI (EMPAGLIFLOZIN + LINAGLIPTIN) is a prescription medicine used to treat proper diet and exercise programs to control high blood sugar in people with type 2 diabetes. EMPAGLIFLOZIN + LINAGLIPTIN also works for controlling blood sugar and helps prevent sexual function, kidney damage, blindness, nerve problems, and loss of limbs. EMPAGLIFLOZIN + LINAGLIPTIN also lessen your risk of a heart attack or stroke. GLYXAMBI manufactured by BOEHRINGER INGELHEIM Pharma Ltd. In Germany.
EMPAGLIFLOZIN + LINAGLIPTIN has to take orally once a day with or without food.
Side Effects :
The most common side effects of EMPAGLIFLOZIN + LINAGLIPTIN are:
Frequent urination, dizziness, or lightheadedness.
The above information comes from the Internet. Please consult with doctor for medical advice.
Suggestion :
* Any advice on the use of the drug is for reference only. Please consult with doctor for medical advice. All Names, logos, trademarks are property of their respective owners. Watermarks, QR code used for identification purposes only.
